Guangzhou Sinanxin Biotech

Guangzhou Sinanxin Biotech is a Chinese biotechnology company specializing in the development of mRNA-based therapeutics and vaccines. The company leverages a proprietary lipid nanoparticle (LNP) delivery platform to create treatments for infectious diseases and various oncology indications. Based in Guangzhou, Sinanxin focuses on optimizing mRNA stability and delivery efficiency to address unmet medical needs in the nucleic acid drug space. Their current pipeline includes preclinical candidates for viral infections and personalized cancer vaccines. The firm is part of a growing cluster of innovative biotech startups in Southern China focused on domestic mRNA technology independence.